162 related articles for article (PubMed ID: 33076370)
1. SOX9 Knockout Induces Polyploidy and Changes Sensitivity to Tumor Treatment Strategies in a Chondrosarcoma Cell Line.
Stöckl S; Lindner G; Li S; Schuster P; Haferkamp S; Wagner F; Prodinger PM; Multhoff G; Boxberg M; Hillmann A; Bauer RJ; Grässel S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076370
[TBL] [Abstract][Full Text] [Related]
2. [Construction and identification of small interfering RNA expression plasmid targeting Sox9 and the function to cell growth and apoptosis of human chondrosarcoma cells HTB94].
Qin HM; Han HF; Xu T; Sha GZ; Liu L; Peng YG; Ren TC
Zhonghua Wai Ke Za Zhi; 2008 May; 46(10):772-5. PubMed ID: 18953935
[TBL] [Abstract][Full Text] [Related]
3. Andrographolide Induces Cell Cycle Arrest and Apoptosis of Chondrosarcoma by Targeting TCF-1/SOX9 Axis.
Zhang HT; Yang J; Liang GH; Gao XJ; Sang Y; Gui T; Liang ZJ; Tam MS; Zha ZG
J Cell Biochem; 2017 Dec; 118(12):4575-4586. PubMed ID: 28485543
[TBL] [Abstract][Full Text] [Related]
4. Different expression of Sox9 and Runx2 between chondrosarcoma and dedifferentiated chondrosarcoma cell line.
Tang X; Lu X; Guo W; Ren T; Zhao H; Zhao F; Tang G
Eur J Cancer Prev; 2010 Nov; 19(6):466-71. PubMed ID: 20683191
[TBL] [Abstract][Full Text] [Related]
5. Direct anti-cancer effect of oncostatin M on chondrosarcoma.
David E; Guihard P; Brounais B; Riet A; Charrier C; Battaglia S; Gouin F; Ponsolle S; Bot RL; Richards CD; Heymann D; Rédini F; Blanchard F
Int J Cancer; 2011 Apr; 128(8):1822-35. PubMed ID: 21344373
[TBL] [Abstract][Full Text] [Related]
6. The epigenetic regulation of SOX9 by miR-145 in human chondrosarcoma.
Mak IW; Singh S; Turcotte R; Ghert M
J Cell Biochem; 2015 Jan; 116(1):37-44. PubMed ID: 25145279
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.
Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K
Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788
[TBL] [Abstract][Full Text] [Related]
8. TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma.
Xu X; Tang X; Guo W; Yang K; Ren T
Tumour Biol; 2016 Oct; 37(10):14129-14140. PubMed ID: 27522523
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of matrilin-3 not only in osteoarthritic articular cartilage but also in cartilage-forming tumors, and down-regulation of SOX9 via epidermal growth factor domain 1-dependent signaling.
Vincourt JB; Vignaud JM; Lionneton F; Sirveaux F; Kawaki H; Marchal S; Lomazzi S; Plénat F; Guillemin F; Netter P; Takigawa M; Mainard D; Magdalou J
Arthritis Rheum; 2008 Sep; 58(9):2798-808. PubMed ID: 18759284
[TBL] [Abstract][Full Text] [Related]
10. Sox9 expression is not limited to chondroid neoplasms: variable occurrence in other soft tissue and bone tumors with frequent expression by synovial sarcomas.
Cajaiba MM; Jianhua Luo ; Goodman MA; Fuhrer KA; Rao UN
Int J Surg Pathol; 2010 Oct; 18(5):319-23. PubMed ID: 20484142
[TBL] [Abstract][Full Text] [Related]
11. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
[TBL] [Abstract][Full Text] [Related]
12. A Novel Regulatory Mechanism of Type II Collagen Expression via a SOX9-dependent Enhancer in Intron 6.
Yasuda H; Oh CD; Chen D; de Crombrugghe B; Kim JH
J Biol Chem; 2017 Jan; 292(2):528-538. PubMed ID: 27881681
[TBL] [Abstract][Full Text] [Related]
13. Molecular profiling of human chondrosarcomas for matrix production and cancer markers.
Söderström M; Böhling T; Ekfors T; Nelimarkka L; Aro HT; Vuorio E
Int J Cancer; 2002 Jul; 100(2):144-51. PubMed ID: 12115562
[TBL] [Abstract][Full Text] [Related]
14. SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma.
Sherman-Samis M; Onallah H; Holth A; Reich R; Davidson B
Gynecol Oncol; 2019 Jun; 153(3):651-660. PubMed ID: 30904337
[TBL] [Abstract][Full Text] [Related]
15. Expression and Therapeutic Potential of SOX9 in Chordoma.
Chen H; Garbutt CC; Spentzos D; Choy E; Hornicek FJ; Duan Z
Clin Cancer Res; 2017 Sep; 23(17):5176-5186. PubMed ID: 28606919
[No Abstract] [Full Text] [Related]
16. Sox9 Modulates proliferation and expression of osteogenic markers of adipose-derived stem cells (ASC).
Stöckl S; Göttl C; Grifka J; Grässel S
Cell Physiol Biochem; 2013; 31(4-5):703-17. PubMed ID: 23711496
[TBL] [Abstract][Full Text] [Related]
17. TGF-β signalling and PEG10 are mutually exclusive and inhibitory in chondrosarcoma cells.
Shinohara N; Maeda S; Yahiro Y; Sakuma D; Matsuyama K; Imamura K; Kawamura I; Setoguchi T; Ishidou Y; Nagano S; Komiya S
Sci Rep; 2017 Oct; 7(1):13494. PubMed ID: 29044189
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-independent gene expression mediated by SOX9 promotes aggressive pancreatic tumor biology.
Camaj P; Jäckel C; Krebs S; De Toni EN; Blum H; Jauch KW; Nelson PJ; Bruns CJ
Mol Cancer Res; 2014 Mar; 12(3):421-32. PubMed ID: 24302456
[TBL] [Abstract][Full Text] [Related]
19. SFMBT2 positively regulates SOX9 and chondrocyte proliferation.
Hussain S; Sun M; Guo Y; Mushtaq N; Zhao Y; Yuan Y; Hussain N; Osoro E; Suleiman A; Sadiq M; Zhang F; Han Y; Sun J; Lu S
Int J Mol Med; 2018 Dec; 42(6):3503-3512. PubMed ID: 30272322
[TBL] [Abstract][Full Text] [Related]
20. Role of LASP-1, a novel SOX9 transcriptional target, in the progression of lung cancer.
Shi J; Guo J; Li X
Int J Oncol; 2018 Jan; 52(1):179-188. PubMed ID: 29138807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]